News
Johnson & Johnson (JNJ) raised its full-year outlook after beating second quarter sales estimates, while tariff concerns ease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback